Chimera Investment (CIM)
(Delayed Data from NYSE)
$15.28 USD
+0.12 (0.79%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $15.27 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$15.28 USD
+0.12 (0.79%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $15.27 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Zacks News
AGNC Investment (AGNC) Issues Update Amid Coronavirus Mayhem
by Zacks Equity Research
AGNC Investment's (AGNC) leverage and liquidity levels benefit from its concerted efforts and the Fed's aggressive actions to support the mortgage market.
Chimera (CIM): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Chimera (CIM) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.
4 REIT Stocks to Buy Amid Coronavirus-Induced Market Maelstrom
by Shuvra Shankar Dey
REITs are considered bond proxies for their high high-dividend paying nature. Their dependence on debt is a positive amid lower borrowing costs due to back-to-back rate cuts.
Top Ranked Income Stocks to Buy for March 20th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 20th
Chimera Investment Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Chimera Investment has been struggling lately, but the selling pressure may be coming to an end soon.
4 Dividend Stocks to Buy Amid Coronavirus-Led Recession Fear
by Shuvra Shankar Dey
Dividend-paying stocks with healthy yields are safe bets now as they have strong prospects, and provide a cushion against large swings in the market.
What Makes Chimera (CIM) a New Strong Buy Stock
by Zacks Equity Research
Chimera (CIM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Top Ranked Income Stocks to Buy for March 11th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 11th
Top Ranked Income Stocks to Buy for March 10th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 10th
Top Rate-Sensitive, Coronavirus-Resistant Picks for You
by Shuvra Shankar Dey
The emergency rate cut, undoubtedly, brings REITs and Utilities at the forefront.
Earnings Preview: Chimera Investment (CIM) Q4 Earnings Expected to Decline
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AGNC Investment's (AGNC) Q4 Earnings Beat Estimates, NII Up
by Zacks Equity Research
AGNC Investment's (AGNC) Q4 earnings reflect growth in comprehensive income per common share and net interest income.
Chimera Investment (CIM) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of -1.96% and -0.64%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AGNC Investment (AGNC) Q2 Earnings Lag Estimates, NII Slips
by Zacks Equity Research
AGNC Investment's (AGNC) Q2 earnings indicate a decline in net interest income. Further, the company's tangible net book value per share witnesses a year-over-year decline.
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chimera (CIM) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Given the recovery in the agency MBS sector, Chimera Investment (CIM) will likely reap benefits of higher exposure to this investment vehicle in Q1.
AGNC Investment's (AGNC) Q1 Earnings Miss, Dividend Cut
by Zacks Equity Research
AGNC Investment (AGNC) first-quarter 2019 earnings indicate a decline in net interest income. Further, the company suggests a decline in its monthly dividends.
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Hold AGNC Investment Stock in Your Portfolio Now?
by Zacks Equity Research
AGNC Investment (AGNC) is making efforts to reposition its portfolio in order to hedge interest rate risks. However, volatile market and choppiness in global economic environment remain concerns.
Chimera Investment (CIM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Chimera Investment (CIM) closed at $18.90, marking a +0.05% move from the previous day.
Top Ranked Income Stocks to Buy for April 8th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 8th:
What Makes Chimera (CIM) a New Strong Buy Stock
by Zacks Equity Research
Chimera (CIM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for March 29th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Is Chimera Investment (CIM) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Is (CIM) Outperforming Other Finance Stocks This Year?